Smith Steven A, Baker Ardith E, Williams John H
Loma Lux Laboratories, Tulsa, OK, USA.
Altern Med Rev. 2002 Feb;7(1):59-67.
Topical over-the-counter remedies exist to aid in the control of seborrheic dermatitis and chronic dandruff on a superficial level. Low-dose systemic oral nickel and bromide therapy has shown promise in providing improvement and eventual clearing of the disease.
The purpose of this study was to further evaluate the effect of an orally administered low-dose, homeopathic mineral therapy (Potassium bromide 1X, Sodium bromide 2X, Nickel sulfate 3X, Sodium chloride 6X) on seborrheic dermatitis and chronic dandruff.
Forty-one patients with seborrheic dermatitis and/or chronic dandruff were assigned to one of two treatment groups: Active (containing the medication) or placebo (vehicle). Study medication was administered in a placebo-controlled, randomly-selected, double-blind study for 10 weeks. At the end of 10 weeks all patients crossed over to the active medication, under a different label for an additional 10 weeks in an open study format.
Twenty-nine patients completed the 10-week blinded portion of the study. After 10 weeks of treatment, the disease state of the active patients improved significantly over that of the placebo patients (p<0.04). The placebo patients' condition before and after crossover to active treatment was also evaluated, showing significant improvement (p<0.01) 10 weeks after crossing over to active medication.
Oral therapy using a low-dose homeopathic preparation combining Potassium bromide 1X, Sodium bromide 2X, Nickel sulfate 3X, and Sodium chloride 6X, provides significant improvement in seborrheic dermatitis and dandruff after 10 weeks of dosing.
市面上存在非处方外用药物,可在浅表层面辅助控制脂溢性皮炎和慢性头皮屑。低剂量系统性口服镍和溴化物疗法已显示出有望改善并最终清除该疾病。
本研究的目的是进一步评估口服低剂量顺势疗法矿物质疗法(溴化钾1X、溴化钠2X、硫酸镍3X、氯化钠6X)对脂溢性皮炎和慢性头皮屑的疗效。
41例患有脂溢性皮炎和/或慢性头皮屑的患者被分配到两个治疗组之一:活性组(含药物)或安慰剂组(赋形剂)。在一项安慰剂对照、随机选择的双盲研究中给予研究药物,为期10周。在10周结束时,所有患者转换为活性药物,以开放研究形式使用不同标签再治疗10周。
29例患者完成了研究的10周盲法部分。治疗10周后,活性组患者的疾病状态较安慰剂组患者有显著改善(p<0.04)。还评估了安慰剂组患者转换为活性治疗前后的情况,结果显示转换为活性药物10周后有显著改善(p<0.01)。
口服低剂量顺势疗法制剂(溴化钾1X、溴化钠2X、硫酸镍3X和氯化钠6X)联合用药10周后,脂溢性皮炎和头皮屑有显著改善。